Moxalactam therapy for a wide spectrum of bacterial infections in adults.

We evaluated the efficacy and toxicity of moxalactam during treatment of 45 documented infections in 36 patients. A majority of patients received 4.5 g of moxalactam per day. There was a good clinical response in 42 of the 45 (94%) infections, including 3 bacteremias, 20 skin and soft tissue infecti...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Tofte, R W, Rotschafer, J, Solliday, J, Crossley, K B
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1981
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181515/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6457555/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.19.5.740
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!